Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Positive crawled date : 2021 - 10 - 15 save search
Genmab Announces that Janssen has Received Positive CHMP Opinion for RYBREVANT® (amivantamab) for Patients with Advanced Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations, After Failure of Platinum-based Therapy
Published: 2021-10-15 (Crawled : 18:00) - globenewswire.com
GNMSF | News | $290.34 0.23% 0
|
Health Technology
|
| O: 0.53%
H: 0.91%
C: 0.91%
JNJ | News | $147.46 -0.72% 820K
|
Health Technology
|
| O: 0.58%
H: 0.0%
C: 0.0%
GMAB | News | $27.69 -2.74% 53K
|
Health Technology
|
| O: 0.41%
H: 1.23%
C: 1.07%
lung cancer positive therapy cancer chmp
Positive Covid-19 Test
Published: 2021-10-15 (Crawled : 17:00) - taylordevices.com
TAYD A | $53.01 -1.43% -1.32% 0
|
Producer Manufacturing
|
| O: 1.3%
H: 0.34%
C: 0.34%
covid test positive covid-19
Merck Receives Positive CHMP Opinion for VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) in Individuals 18 Years of Age and Older
Published: 2021-10-15 (Crawled : 14:00) - biospace.com/
MRK | $131.065 3.2% 2.5M
|
Health Technology
|
| O: -0.17%
H: 1.1%
C: 0.17%
positive chmp vaccine order pneumococcal
Bristol Myers Squibb Receives Positive CHMP Opinion for Zeposia (ozanimod) as a Treatment for Adult Patients with Moderately to Severely Active Ulcerative Colitis
Published: 2021-10-15 (Crawled : 14:00) - biospace.com/
BMY | $46.72 -4.38% 2M
|
Health Technology
|
| O: 0.71%
H: 1.0%
C: 0.43%
treatment positive chmp ulcerative colitis
Sacituzumab Govitecan Receives Positive CHMP Opinion as 2L Treatment for Adult Patients With Metastatic Triple-Negative Breast Cancer
Published: 2021-10-15 (Crawled : 14:00) - biospace.com/
GILD | $66.69 -0.58% 850K
|
Health Technology
|
| O: 0.9%
H: 0.0%
C: 0.0%
treatment positive cancer chmp breast cancer als
AbbVie Receives CHMP Positive Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Active Psoriatic Arthritis in the European Union (EU)
Published: 2021-10-15 (Crawled : 13:15) - biospace.com/
ABBV | News | $168.67 0.52% 260K
|
Health Technology
|
| O: 0.22%
H: 0.74%
C: 0.16%
treatment europe positive risankizumab chmp
Aspaveli® (pegcetacoplan) receives positive CHMP opinion for treatment of PNH
Published: 2021-10-15 (Crawled : 12:00) - prnewswire.com
APLS G | $48.52 -2.82% 43K
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: -2.48%
treatment positive chmp
Apellis and Sobi Receive Positive CHMP Opinion for Aspaveli® (pegcetacoplan) for the Treatment of PNH
Published: 2021-10-15 (Crawled : 12:00) - globenewswire.com
APLS G | $48.52 -2.82% 43K
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: -2.48%
treatment positive chmp
Relief Reports U.S. Collaboration Partner Announces Journal of Infectious Diseases and Treatment Publishes Positive Aviptadil Data in High Comorbidity Critical COVID-19 Patients w/ Respiratory Failure
Published: 2021-10-15 (Crawled : 09:00) - biospace.com/
NRXP 5 d | $3.05 -2.24% 9.5K
|
Manufacturing
|
| O: -6.63%
H: 2.97%
C: -7.73%
covid disease treatment aviptadil infectious disease positive collaboration respiratory
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
CSSE 4 | $0.299 96.32% 7M
|
Consumer Services
BRFH 4 | $1.99 80.91% 13M
|
Manufacturing
LICN | $1.0 78.57% 3.3M
|
BOF | $1.915 63.68% 620K
|
MTC | $3.62 61.61% 790K
|
Technology Services
AMST | $3.13 56.5% 500K
|
Technology Services
ACON | $0.3595 24.83% 3.5M
|
n/a
ILAG | $0.669 23.89% 13M
|
CDTX | News | $14.57 18.55% 330K
|
Health Technology
MNY | $2.11 17.22% 180K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.